Epithelial sodium channel blocker
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by GreenC bot (talk | contribs) at 01:52, 23 May 2022 (Rescued 1 archive link. Wayback Medic 2.5). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 01:52, 23 May 2022 by GreenC bot (talk | contribs) (Rescued 1 archive link. Wayback Medic 2.5)
An epithelial sodium channel blocker is a sodium channel blocker that is selective for the epithelial sodium channel.
An example is amiloride, which is used in the treatment of hypertension.[1]
References
- ^ Sagnella GA, Swift PA (2006). "The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure". Curr. Pharm. Des. 12 (18): 2221–34. doi:10.2174/138161206777585157. PMID 16787251. Archived from the original on April 14, 2013.
| Sulfonamides (and etacrynic acid) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Potassium-sparing (at CD) |
| ||||||||
| Osmotic diuretics (PT, DL) | |||||||||
| Vasopressin receptor inhibitors (DCT and CD) | |||||||||
| Other | |||||||||
| Combination products | |||||||||
| |||||||||
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |